Potential of low molecular weight natural polysaccharides for colon targeted formulation and its evaluation in human by Gamma Scintigraphy
- 3 Downloads
Colonic drug targeting is an elusive goal, implicated for localized drug and systemic delivery of proteins which otherwise cannot be delivered by oral route. The purpose of the present work was to evaluate the suitability of formulation design of compression coating and potential of low molecular weight natural polysaccharides for colonic drug targeting using Gamma Scintigraphy in human subjects and to establish platform technology.
Before commencing with in vivo imaging studies in human by Gamma Scintigraphy, we performed in vitro release studies and scanning electron microscopy for surface topography of tablet formulations subjected to in vitro dissolution study.
We investigated the applicability of low molecular weight and low viscosity grade Guar gum ULV 1000 and Pectin with low degree of methoxylation 9% as for site specific delivery. Gamma Scintigraphy imaging of formulation with biopolymer in human subject showed the transit of tablet intact in colon with average arrival time being 5.75 h and the activity was released continuously for 30 h. Scanning electron microscopy for surface topography of tablets subjected to simulated colonic fluid showed erosion caused by microbial flora of the colon.
Taken together, compression coating design with low molecular weight biopolymer can serve as a platform technology to deliver other potential molecules to the colonic region for local and/or systemic effects in other therapeutic areas.
KeywordsGamma Scintigraphy Scanning electron microscopy Guargum ULV 1000 Pectin Tc DTPA 99m Colon targeted drug delivery polymers
The authors would like to acknowledge The Board of Radiation and Nuclear Sciences, Department of Atomic Energy, Bhabha Atomic Research Centre (BARC), India forfunding this project (BARC GRANT 98/35/5/932).
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
Statement of human and animal rights
All healthy human participated in imaging studies were voluntarily involved with their written consent as per the local institutional ethical guidelines. The purpose of the study was explained to them and the experimental protocol was approved by the Ethical Committee of the Radiation Medicine Centre, Tata Memorial Hospital, Mumbai.
- Banker GS, Rhodes CT (2002) Sustained and controlled release drug delivery system, 4th edn. Marcel Dekker, New YorkGoogle Scholar
- Basit A, Bloor J (2003) Perspectives on colonic drug delivery, business briefing. Pharm Technol 2003:185–190Google Scholar
- Chien YW (1992) Novel drug delivery, systems, revised and expanded, 2nd edn. Marcel Dekker, New YorkGoogle Scholar
- Chourasia MK, Jain SK (2003) Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Sci 6:33–66Google Scholar
- Goto T, Tanida N, Yoshinaga T, Sato S, Ball DJ, Wilding IR, Kobayashi E, Fujimura A (2004) Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans. J Control Release 97:31–42CrossRefGoogle Scholar
- Lee VH, Robinson JR (1998) Sustained and controlled release drug delivery system. Marcel Dekker, New YorkGoogle Scholar
- Mackay M, Tomlinson E (1993) Colonic delivery of therapeutic peptides and proteins. In: Biek PR (ed) Colonic drug absorption and metabolism. Marcel Dekker, New YorkGoogle Scholar
- Rowe RC, Sheskey PJ, Quinn ME (2009) Handbook of pharmaceutical excipients, 6th edn. Pharmaceutical Press, American Pharmacists Association, Washington, D.C., p 298Google Scholar